Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Buccisano

Showing results (21-30 of 143) with videos related to

Pageof 15
Sort By:
The Hematology Journal : the Official Journal of the European Haematology Association|July 23, 2003
Comparison between conventional banding analysis and FISH screening with an AML-specific set of probes in 260 patientsMaria Christina Cox, Paola Panetta, Adriano Venditti, et al.
Frontiers in Medicine|July 2, 2015
NK Cell Inflammation in the Clinical Outcome of Colorectal CarcinomaAndrea Coppola, Roberto Arriga, Davide Lauro, et al.
Journal of Hematotherapy & Stem Cell Research|May 2, 2002
Clinical relevance of minimal residual disease detection in adult acute myeloid leukemiaAdriano Venditti, Anna Tamburini, Francesco Buccisano, et al.
Current Opinion in Oncology|August 12, 2009
Monitoring of minimal residual disease in acute myeloid leukemiaFrancesco Buccisano, Luca Maurillo, Alessandra Spagnoli, et al.
Blood|November 1, 2011
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemiaFrancesco Buccisano, Luca Maurillo, Maria Ilaria Del Principe, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 26, 2022
The Venetoclax/Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient with COVID-19Antonio Cristiano, Raffaele Palmieri, Emiliano Fabiani, et al.
Cancers|January 8, 2020
Therapeutic Choice in Older Patients with Acute Myeloid Leukemia: A Matter of FitnessRaffaele Palmieri, Giovangiacinto Paterno, Eleonora De Bellis, et al.
International Journal of Molecular Sciences|February 25, 2023
Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AMLElisa Meddi, Arianna Savi, Federico Moretti, et al.
The Journal of Molecular Diagnostics : JMD|April 12, 2008
An allele-specific rt-PCR assay to detect type A mutation of the nucleophosmin-1 gene in acute myeloid leukemiaTiziana Ottone, Emanuele Ammatuna, Serena Lavorgna, et al.
European Journal of Haematology|November 15, 2002
Autologous stem-cell transplantation for patients with acute myeloid leukemia aged over 60 yrFelicetto Ferrara, Adriano Venditti, Angelo Michele Carellajr, et al.
Pageof 15

Showing results (21-30 of 143) with videos related to

Sort By:
Pageof 15
The Hematology Journal : the Official Journal of the European Haematology Association|July 23, 2003
Comparison between conventional banding analysis and FISH screening with an AML-specific set of probes in 260 patientsMaria Christina Cox, Paola Panetta, Adriano Venditti, et al.
Frontiers in Medicine|July 2, 2015
NK Cell Inflammation in the Clinical Outcome of Colorectal CarcinomaAndrea Coppola, Roberto Arriga, Davide Lauro, et al.
Journal of Hematotherapy & Stem Cell Research|May 2, 2002
Clinical relevance of minimal residual disease detection in adult acute myeloid leukemiaAdriano Venditti, Anna Tamburini, Francesco Buccisano, et al.
Current Opinion in Oncology|August 12, 2009
Monitoring of minimal residual disease in acute myeloid leukemiaFrancesco Buccisano, Luca Maurillo, Alessandra Spagnoli, et al.
Blood|November 1, 2011
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemiaFrancesco Buccisano, Luca Maurillo, Maria Ilaria Del Principe, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 26, 2022
The Venetoclax/Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient with COVID-19Antonio Cristiano, Raffaele Palmieri, Emiliano Fabiani, et al.
Cancers|January 8, 2020
Therapeutic Choice in Older Patients with Acute Myeloid Leukemia: A Matter of FitnessRaffaele Palmieri, Giovangiacinto Paterno, Eleonora De Bellis, et al.
International Journal of Molecular Sciences|February 25, 2023
Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AMLElisa Meddi, Arianna Savi, Federico Moretti, et al.
The Journal of Molecular Diagnostics : JMD|April 12, 2008
An allele-specific rt-PCR assay to detect type A mutation of the nucleophosmin-1 gene in acute myeloid leukemiaTiziana Ottone, Emanuele Ammatuna, Serena Lavorgna, et al.
European Journal of Haematology|November 15, 2002
Autologous stem-cell transplantation for patients with acute myeloid leukemia aged over 60 yrFelicetto Ferrara, Adriano Venditti, Angelo Michele Carellajr, et al.
Pageof 15